Vaccines MDPI

28/07/2025

📣 We would like to share the highly cited review "Malaria Vaccines: From the Past towards the mRNA Vaccine Era"

✍️ By Maria E. Tsoumani, Chrysa Voyiatzaki and Antonia Efstathiou

👉Access for free: https://brnw.ch/21wUu14

Plasmodium spp. is the etiological agent of malaria, a life-threatening parasitic disease transmitted by infected mosquitoes. Malaria remains a major global health challenge, particularly in endemic regions. Over the years, various vaccine candidates targeting different stages of Plasmodium parasite...

28/07/2025

📣 Come and see us at The 8th International Conference on Prevention & Infection Control

🌍Place: Geneva, Switzerland
📆 Date: 16–19 September 2025

The 17th Academic Conference of the Chinese Pharmacological Society serves as an interdisciplinary forum for the prompt exchange of recent achievements, experiences, theories, technologies, and methods in China's pharmacology research domain, in addition to new drug development and related fields. The conference will promote the innovative development of China's pharmacology research and new drug development on a longer-term basis.

👉 For more info: https://brnw.ch/21wUtIV

,

Conference: The 8th International Conference on Prevention & Infection Control Date: 16–19 September 2025Location: Geneva, Switzerland
MDPI will be attending the...

28/07/2025

📣 Special Issued Deadline Extension!

"Human Leukocyte Antigen (HLA)—Antigen Interactions in Vaccine Development"

👤Guest Editor: Prof. Dr. Apostolos P. Georgopoulos

📆 Deadline extended to: 31 July 2026

This Special Issue welcomes original research articles and reviews on research areas focusing on antigen–HLA interactions in vaccine development and vaccine effectiveness. Research or review articles on the role of HLA in antigen presentation, antibody production, and vaccine effectiveness are also welcome.

👉 For more information and to submit please visit: https://brnw.ch/21wUtxM

, , , , , ,

Vaccines, an international, peer-reviewed Open Access journal.

28/07/2025

📣 We would like to share the newly published review "Engaging Broader Stakeholders to Accelerate Group A Streptococcus Vaccine Development"

✍️ By Dechuan Kong , Hao Pan, Huanyu Wu and Jian Chen from Shanghai Municipal Center for Disease Control and Prevention, China

👉Access for free: https://brnw.ch/21wUtlN

; ; ;

Group A Streptococcus (GAS) imposes a significant global health burden across all age groups, annually causing over 600 million cases of pharyngitis and more than 18 million severe invasive infections or sequelae. The resurgence of scarlet fever globally and streptococcal toxic shock syndrome (STSS)...

28/07/2025

📣 3 Days left to submit an abstract for The 3rd International Online Conference on Vaccines

📆Submission Deadline: 31 July 2025
📆Conference Date: 26-28 November 2025

👉To submit or for more details please visit: https://brnw.ch/21wUtbI

, , , ,

25/07/2025

📣 Check out the highly viewed Article "Exploring the Challenges of Lipid Nanoparticle Development: The In Vitro–In Vivo Correlation Gap"

✍️ By Sarah Lindsay, Muattaz Hussain, Burcu Binici and Yvonne Perrie from the University of Strathclyde

👉Access for free: https://brnw.ch/21wUqqk

, , , , , , ,

Background/Objectives: The development of lipid nanoparticles (LNPs) as delivery platforms for nucleic acids has revolutionised possibilities for both therapeutic and vaccine applications. However, emerging studies highlight challenges in achieving reliable in vitro–in vivo correlation (IVIVC), wh...

25/07/2025

🎉 We are pleased to announce the launch of a new Special Issue!

"Advances in Plant Genetic Engineered Vaccines"

👤Guest Editor: Dr. John Howard

This Special Issue focuses on plant systems that can be used to improve vaccinations. Plants can serve as factories for producing biopharmaceuticals and vaccines. The advantages of plant-based production platforms include easy scale-up, cost-effectiveness, and high safety, as plants are not hosts for human and animal pathogens. The objective of this issue is to highlight the advantages and progress toward commercialization in various systems and discuss vaccination approaches.

🗓 Deadline for manuscript submissions: 30 April 2026

👉 For more information and to submit please visit: https://brnw.ch/21wUqct

Vaccines, an international, peer-reviewed Open Access journal.

25/07/2025

📣 We would like to share the newly published article "Evaluation of Peptide-Based Vaccines Against Group A Streptococcus in Staphylococcus aureus-Infected Mice"

✍️ By Ahmed O. Shalash, Haolan Sun, Yiru Cui, Jingwen Wang, Barb Arnts, Jannah Bauer, Waleed M. Hussein, Zeinab G. Khalil, Mariusz Skwarczynski and Istvan Toth from The University of Queensland, Australia

👉Access for free: https://brnw.ch/21wUq18

; ; ; ; ;

Background: Group A Streptococcus (GAS) is a major human pathogen associated with serious diseases. Evaluating immune responses against GAS vaccines—immunogenicity, quality, and efficacy—is complicated by interference from co-infections, like Staphylococcus aureus (S. aureus). We aimed to evalua...

25/07/2025

The 3rd International Online Conference on Vaccines https://brnw.ch/21wUpQ7

🗓️ 26–28 November 2025 (Central European Time)

We are pleased to warmly welcome our Committee member for S3. Models for Vaccine Development and Evaluation🎉

Professor Uladzimir Karniychuk, Department of Veterinary Biosciences, The Ohio State University, Columbus, USA

📅 Important Dates to Remember:
- Abstract Submission Deadline: July 31, 2025
- Notification of Abstract Acceptance: August 29, 2025
- Registration Deadline: November 23, 2025

, , , , , ;

The 3rd International Online Conference on Vaccines

25/07/2025

📣 Check out the notable papers from 2024 in the section “Epidemiology” here https://brnw.ch/21wUpF3

👉Access for free: “Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy” https://brnw.ch/21wUpF0

👉Access for free: “Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019–2023: From Challenges to Opportunities” https://brnw.ch/21wUpEV

👉Access for free: “Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics” https://brnw.ch/21wUpEX

👉Access for free: “Congenital Rubella Syndrome Does Not Increase with Introduction of Rubella-Containing Vaccine” https://brnw.ch/21wUpEZ

👉Access for free: “The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance” https://brnw.ch/21wUpEY

👉Access for free: “An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity” https://brnw.ch/21wUpF2

👉Access for free: “Assessment of Epidemiological Trend of Influenza-Like Illness in Italy from 2010/2011 to 2023/2024 Season: Key Points to Optimize Future Vaccination Strategies against Influenza” https://brnw.ch/21wUpEU

👉Access for free: “Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data” https://brnw.ch/21wUpET

👉Access for free: “Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries” https://brnw.ch/21wUpF1

👉Access for free: “Serosurveillance for Measles and Rubella” https://brnw.ch/21wUpEW

; ; ;

1. “Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy” by Andrea Ceccarelli, Federica Tamarri,...

24/07/2025

📣 We would like to share the highly cited article "Antibody-Dependent Enhancement Activity of a Plant-Made Vaccine against West Nile Virus"

✍️ By Haiyan Sun, Dhiraj Acharya, Amber M. Paul, Huafang Lai, Junyun He, Fengwei Bai and Qiang Chen

👉Access for free: https://brnw.ch/21wUoAd

; ; ; ; ; ; ;

West Nile virus (WNV) causes annual outbreaks globally and is the leading cause of mosquito-borne disease in Unite States. In the absence of licensed therapeutics, there is an urgent need to develop effective and safe human vaccines against WNV. One of the major safety concerns for WNV vaccine devel...

24/07/2025

🎉 New Special Issue Launched!

"Integrating Vaccination/Immunization Services into Universal Health Coverage"

👤Guest Editor: Dr. Anelisa Jaca

The World Health Assembly and the UN General Assembly have urgently called on nations to prioritize efforts to accelerate the transition to Universal Health Coverage (UHC). UHC is having “access to affordable and quality health care services by all individuals, irrespective of their financial status”. However, achieving UHC poses ongoing challenges and barriers, with approximately 4.5 billion individuals still lacking access to quality and essential healthcare services, which include, among other services, childhood vaccination and immunization. Immunization, which is one of the most cost-effective life-saving health interventions, is an essential component that should be integrated into UHC. In effect, this implies that immunization is one of the health services that countries should ensure is accessible and affordable, by including it in their UHC packages. Achieving UHC also involves identifying and addressing barriers to vaccination and vaccine supply chain issues.

🗓 Deadline for manuscript submissions: 30 June 2026

👉 For more information and to submit please visit: https://brnw.ch/21wUokw

Vaccines, an international, peer-reviewed Open Access journal.